<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
<channel>
<title>CTI - Whistleblower Law Blog</title>
<link>http://whistleblower.labovick.com/articles/whistleblower-articles/health-care-fraud/medicare-fraud/</link>
<description></description>
<language>en-us</language>
<copyright>Copyright 2008</copyright>
<lastBuildDate>Wed, 18 Apr 2007 09:23:09 -0500</lastBuildDate>
<pubDate>Tue, 08 Jul 2008 12:26:37 -0500</pubDate>
<generator>http://www.movabletype.org/?v=3.34</generator>
<docs>http://blogs.law.harvard.edu/tech/rss</docs> 

<item>
<title>CTI pays $10.5 Million to Settle Medicare Qui Tam Suit</title>
<description><![CDATA[<p>Cell Therapeutics, Inc. (CTI)&nbsp;settled all government claims arising out of a Department of Justice investigation into allegations regarding alleged overpayments by Medicare to doctors who prescribed the anti-cancer drug, TRISENOX. <a href="http://www.smartbrief.com/news/fdli/industryPR-detail.jsp?id=19FF139F-2ED8-4174-B8E3-7A864D51EFAF">As part of the settlement, CTI will pay $10.5 million plus interest</a> and the Department of Justice has agreed to fully release CTI from all liability for the issues under investigation, including claims asserted in a qui tam lawsuit. The terms of the settlement contain no admission of wrongdoing by CTI. </p><p>According to a recent <a href="http://seattletimes.nwsource.com/html/businesstechnology/2003670653_cell18.html">Seattle Times Article</a>, Peter Kessler, &nbsp;Assistant Attorney General for the Justice Department's Civil Division, stated &quot;They misled a lot of doctors by telling them that the drug was medically accepted.&quot;&nbsp; Cell Therapeutics blamed&nbsp;<a href="http://seattletimes.nwsource.com/html/businesstechnology/2003670653_cell18.html">Medicare billing issues</a> on&nbsp;consulting firm,&nbsp;Lash Group, a unit of pharmaceuticals distributor AmerisourceBergen. Lash denies the company's allegations. </p>
<p><br /><a href="http://seattletimes.nwsource.com/html/businesstechnology/2003670653_cell18.html">Click Here to read more on the Seattle Times Article</a> <a href="http://www.smartbrief.com/news/FDLI/industryPR-detail.jsp?id=19FF139F-2ED8-4174-B8E3-7A864D51EFAF&amp;sb_code=RSS&amp;i=Biopharmaceuticals%20%26%20Biotherapeutics"><br /></a><br /></p><p>&nbsp;</p>]]></description>
<link>http://whistleblower.labovick.com/2007/04/articles/whistleblower-articles/health-care-fraud/medicare-fraud/cti-pays-105-million-to-settle-medicare-qui-tam-suit/</link>
<guid isPermaLink="false">http://whistleblower.labovick.com/2007/04/articles/whistleblower-articles/health-care-fraud/medicare-fraud/cti-pays-105-million-to-settle-medicare-qui-tam-suit/</guid>
<category>CTI</category><category>Cell Therapeutics</category><category>Medicare Fraud</category><category>Medicare Qui Tam Fraud</category><category>qui tam</category>
<pubDate>Wed, 18 Apr 2007 09:23:09 -0500</pubDate>
<author>Juliet@LaBovick.com (LaBovick Law)</author>

</item>


</channel>
</rss>